TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
95.85
-1.23 (-1.27%)
May 5, 2026, 11:06 AM EDT - Market open

TransMedics Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,3114,1692,0962,5791,984532
Market Cap Growth
10.92%98.88%-18.72%29.99%272.55%-1.54%
Enterprise Value
3,3314,1862,2752,6981,849483.84
Last Close Price
95.85121.6562.3578.9361.7219.16
PE Ratio
19.6724.9861.73-102.51-50.18-11.97
Forward PE
39.0047.4056.70---
PS Ratio
5.456.884.7510.6721.2317.60
PB Ratio
7.038.819.1718.8010.597.85
P/TBV Ratio
8.2110.429.6118.719.747.80
P/FCF Ratio
24.7131.21-25.90-15.64-34.37-16.44
P/OCF Ratio
17.1221.6242.95-197.94-43.30-18.45
EV/Sales Ratio
5.506.915.1511.1719.7815.99
EV/EBITDA Ratio
24.7730.8339.74-131.28-66.12-12.86
EV/EBIT Ratio
30.6838.5560.67-93.91-58.81-12.27
EV/FCF Ratio
24.9431.34-28.11-16.36-32.03-14.94
Debt / Equity Ratio
1.071.072.263.750.350.65
Debt / EBITDA Ratio
3.833.839.05-25.11-2.42-1.16
Debt / FCF Ratio
3.893.89-6.40-3.13-1.17-1.35
Net Debt / Equity Ratio
0.070.070.800.88-0.71-0.72
Net Debt / EBITDA Ratio
0.230.233.17-5.894.781.29
Net Debt / FCF Ratio
0.230.23-2.24-0.732.321.50
Asset Turnover
0.650.650.580.490.450.21
Inventory Turnover
5.095.093.952.701.590.68
Quick Ratio
6.416.417.258.349.674.23
Current Ratio
7.147.148.309.3010.665.11
Return on Equity (ROE)
54.24%54.24%19.39%-15.42%-28.39%-51.49%
Return on Assets (ROA)
2.67%2.67%5.01%-6.20%-15.23%-27.46%
Return on Invested Capital (ROIC)
5.44%5.44%11.25%-19.41%-85.45%-230.24%
Return on Capital Employed (ROCE)
12.60%12.60%5.37%-6.35%-17.22%-31.32%
Earnings Yield
5.77%4.00%1.62%-0.98%-1.99%-8.35%
FCF Yield
4.05%3.20%-3.86%-6.39%-2.91%-6.08%
Buyback Yield / Dilution
-15.12%-15.12%-8.30%-10.02%-7.02%-11.80%
Total Shareholder Return
-15.12%-15.12%-8.30%-10.02%-7.02%-11.80%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q